This Reddit Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

Comments
Loading...

Top Wall Street analysts initiated coverage on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

  • HC Wainwright & Co. analyst Mitchell Kapoor initiated coverage on Ionis Pharmaceuticals, Inc. IONS with a Buy rating and announced a price target of $45. Ionis Pharmaceuticals shares closed at $27.09 on Friday. See how other analysts view this stock.
  • Jefferies analyst Andrew Tsai initiated coverage on Axsome Therapeutics, Inc. AXSM with a Buy rating and announced a price target of $200. Axsome Therapeutics shares closed at $98.86 on Friday. See how other analysts view this stock.
  • Wells Fargo analyst John Kilichowski initiated coverage on NETSTREIT Corp. NTST with an Overweight rating and announced a price target of $18. Netstreit shares closed at $15.28 on Friday. See how other analysts view this stock.
  • Truist Securities analyst Youssef Squali initiated coverage on Reddit, Inc. RDDT with a Buy rating and announced a price target of $150. Reddit shares closed at $86.91 on Friday. See how other analysts view this stock.
  • RBC Capital analyst Greg Renza initiated coverage on BeiGene, Ltd. ONC with an Outperform rating and announced a price target of $312. BeiGene shares closed at $238.51 on Friday.  See how other analysts view this stock.

Considering buying RDDT stock? Here’s what analysts think:

Read This Next:

Photo via Shutterstock

AXSM Logo
AXSMAxsome Therapeutics Inc
$100.712.24%

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score
Edge Rankings
Momentum
93.22
Growth
-
Quality
-
Value
12.47
Price Trend
Short
Medium
Long
Got Questions? Ask
Which biotech companies could follow Ionis?
How might Axsome Therapeutics leverage its new rating?
What impact will NETSTREIT's rating have on REITs?
Which tech firms could benefit from Reddit's growth?
Could BeiGene attract more investment after its rating?
How will analysts' ratings affect market sentiment?
Which pharmaceuticals are poised for similar upgrades?
Is Reddit set to disrupt digital advertising?
What trends in healthcare investments could emerge from these ratings?
Which stocks are undervalued in light of new analyst coverage?
Market News and Data brought to you by Benzinga APIs
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm

Posted In: